Results 91 to 100 of about 21,677 (267)

Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management

Medicinal Research Reviews, Volume 46, Issue 1, Page 272-298, January 2026.
ABSTRACT Neurodegenerative disorders, including Alzheimer's disease (AD), impose a significant burden on society due to their progressive nature and the associated healthcare costs. Autophagy, a vital cellular degradation process, has emerged as a promising therapeutic target in these disorders.
Baljinder Singh, Shubham Mahajan, Sadikalmahdi Abdella, Rehan Khan, Sanjay Garg   +4 more
wiley   +1 more source

Medium‐Dose Formoterol Attenuated Abdominal Aortic Aneurysm Induced by EPO via β2AR/cAMP/SIRT1 Pathway

Advanced Science
Abdominal aortic aneurysm (AAA) is a life‐threatening vascular disease but effective drugs for treatment of AAA are still lacking. Recently, erythropoietin (EPO) is reported to induce AAA formation in apolipoprotein‐E knock out (ApoE−/−) mice but an ...
Jianlin Zhang, Yu Cao, Ruiqing Ren, Wenhai Sui, Yun Zhang, Meng Zhang, Cheng Zhang   +6 more
doaj   +1 more source

The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease (Review) [PDF]

, 2011
BackgroundLong-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropiumare commonly used, either on their own or in combination, for managing persistent symptoms of chronic obstructive pulmonary disease ...
Aaron, Aaron, Agarwal, Akazawa, Appleton, Barr, Beeh, Berger, Briggs, Calverley, Dalal, Effing, Higgins, Hutchinson, Johnson, Kaplan, Lacasse, Meer, Najafzadeh, Najafzadeh, Nannini, Nannini Luis, Proskocil, Rodrigo, Rodrigo, Roisman, Singh, Singh, Tanaka, Tashkin, Wallukat, Welsh, Yang   +32 more
core   +1 more source

Formoterol Acting via β2-Adrenoreceptor Restores Mitochondrial Dysfunction Caused by Parkinson’s Disease-Related UQCRC1 Mutation and Improves Mitochondrial Homeostasis Including Dynamic and Transport

Biology
Formoterol, a β2-adrenergic receptor (β2AR) agonist, shows promise in various diseases, but its effectiveness in Parkinson’s disease (PD) is debated, with unclear regulation of mitochondrial homeostasis.
Jui-Chih Chang, Huei-Shin Chang, Yi-Chun Chao, Ching-Shan Huang, Chin-Hsien Lin, Zhong-Sheng Wu, Hui-Ju Chang, Chin-San Liu, Chieh-Sen Chuang   +8 more
doaj   +1 more source

Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial

BMC Pulmonary Medicine, 2012
Background This study investigated the efficacy and safety of a new asthma therapy combining fluticasone propionate and formoterol fumarate (fluticasone/formoterol; flutiform®), administered twice daily (b.i.d.) via a single aerosol inhaler, compared ...
Nathan Robert A, D’Urzo Anthony, Blazhko Viktor, Kaiser Kirsten   +3 more
doaj   +1 more source

Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial [PDF]

, 2017
Asthma mortality surveys report delays in seeking medical review and overuse of beta-agonist therapy as factors contributing to a fatal outcome. However, the strength of these associations is limited because many asthma deaths are unwitnessed.
Beasley, Richard, Black, Peter, Braithwaite, Irene, Ebmeier, Stefan, Patel, Mitesh, Pilcher, Janine, Pritchard, Alison, Shaw, Dominick E., Thayabaran, Darmiga, Weatherall, Mark   +9 more
core   +1 more source

Budesonide-Glycopyrronium-Formoterol Fumarate Dihydrate (Breztri Aerosphere)

, 2021
Reimbursement Team
openalex   +2 more sources

Cost comparison of asthma treatments in 12-week study : caution about matching and short observational follow-up [PDF]

, 2016
This review was funded by Observational and Pragmatic Research Institute Pte Ltd.Peer reviewedPublisher ...
Cifra, Alessandra, Law, Lisa M., McQueen, R Brett, Price, David B., van Boven, Job F. M.   +4 more
core   +3 more sources

Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol

International Journal of COPD, 2017
Vaidyanathan Ganapathy,1 Michael D Stensland2 1Sunovion Pharmaceuticals Inc., Marlborough, MA, 2Agile Outcomes Research, Inc., Rochester, MN, USA Objective: Arformoterol is the (R,R)-enantiomer of formoterol.
Ganapathy V, Stensland MD
doaj  

Cost-effectiveness of budesonide-formoterol in maintenance therapy of asthma patients at Mexico’s National Center for Respiratory Diseases.

Revista Alergia México
Objective: to perform a cost-effectiveness analysis of asthma treatment with budesonide/formoterol against other treatment options used at Mexico’s National Institute for Respiratory Diseases.
María del Carmen Cano-Salas, José L. Miguel-Reyes, Erika C. López-Estrada, Jorge Salas-Hernández, Monserrat E. Arroyo-Rojas, Mauricio Castañeda-Valdivia, Monserrat Escobar-Preciado, Homero Garcés-Flores, Silvia Guzmán- Vázquez, Sergio R. García-García, Herman Soto-Molina   +10 more
doaj   +1 more source